JIC Venture Growth Investments
Edit

JIC Venture Growth Investments

https://www.j-vgi.co.jp
Last activity: 25.08.2026
Active
Invests in categories: AdTechAppDevelopmentDrugEnergyTechMedtechPlatformServiceSpaceTechnology
ベンチャー・グロース投資活動により日本のイノベーションを促進し国際競争力の向上に寄与。日本の産業及び社会課題の解決を目指す。
Portfolio
70
Mentions
9

Portfolio 70

DateNameWebsiteTotal RaisedLocation
25.08.2026HERP, Inc.herp.co.jp-Japan
24.08.2026Letaraletara.space-Japan
21.07.2026Rege Nephr...regenephro.co.jp$10.6MJapan
09.03.2024Gaianixx I...gaianixx.com-Japan, Bun...
09.03.2024Instalimb,...instalimb.com-Japan, Set...
10.02.2024Enechangeenechange.co.jp$4.4MJapan, Tok...
08.02.2024KYCコンサルティン...kycc.co.jp-Japan, Tok...
10.01.2024Sosei Hept...soseiheptares.com$200MJapan, Cho...
10.01.2024Shinobi Th...shinobitx.com$110M-
10.01.2024Restore Vi...restore-vis.com--
Show more

Mentions in press and media 9

DateTitleDescription
25.08.2026HERP Raises ¥1.9 Billion Series C Led By JIC VGI As It Plans To Triple Team To 300HERP has raised approximately ¥1.9 billion in Series C financing to expand its AI-powered recruiting platform and matching businesses, bringing the Japanese HR technology company’s cumulative funding to approximately ¥3.4 billion. JIC Ventu...
24.08.2026Letara Raises About $16.3 Million Pre-Series A As Plastic-Fueled Hybrid Rocket Engine Wins Government And Commercial OrdersLetara has raised approximately ¥2.6 billion, or about $16.3 million, in a Pre-Series A financing round to accelerate development and commercialization of its low-cost, mass-producible hybrid rocket engines for launch, on-orbit propulsion, ...
23.07.2026Rege Nephro Secures $10.6 Million for Kidney Disease InnovationsRege Nephro, a pioneering biotechnology firm, has secured approximately $10.6 million in new financing. This crucial capital propels its innovative kidney disease pipeline. Funds will advance RN-014, a lead candidate for Autosomal Dominant ...
21.07.2026Rege Nephro Secures approximately US$10.6 Million to Advance RN-014 Toward CommercializationFinancing will support development of RN-014 and RN-032 and continued expansion of the company's kidney disease pipeline KYOTO, Japan, July 21, 2026 /PRNewswire/ -- Rege Nephro Co., Ltd. ("Rege Nephro"), a clinical-stage biotechno...
21.07.2026Rege Nephro Raises $10.6 Million To Advance RN-014 And Kidney Regeneration PipelineRege Nephro has raised approximately $10.6 million to advance its kidney disease programs, including lead candidate RN-014 and regenerative medicine program RN-032. The clinical-stage biotechnology company completed the financing through th...
11.06.2026Beren Therapeutics Secures $300 Million Financing To Support Potential Adrabetadex LaunchBeren Therapeutics announced a combined $300 million financing package to support the potential commercial launch of adrabetadex and expand long-term patient access and family support initiatives for infantile-onset Niemann-Pick disease typ...
25.04.2025Ex-Lazada exec’s edtech startup nets $23m series BInvestmentsNewsStartups Randy Mulyanto · 2d ago · 2 min readEx-Lazada exec’s edtech startup nets $23m series B Manabie, an edtech startup based in Singapore, has raised around US$23 million in a series B round led by JIC Venture Growth Inve...
19.10.2024Sun Metalon Raises $21 Million to Enhance Its New Metal Recycling TechnologySun Metalon, a start-up specializing in sustainable metal manufacturing, has successfully raised $21 million in a Series A funding round. This includes a $3.4 million loan facility from Sumitomo Mitsui Banking Corporation, bringing the comp...
11.05.2022Japan’s Zeals raises $38.8M to scale its chat commerce platformZeals, a Tokyo-based startup that lets businesses communicate with their customers via its chat application, said Thursday it has secured $27.2 million (3.5 billion yen) in equity and $11.6 million (1.5 billion yen) in debt. The latest roun...

Reviews 0

Sign up to leave a review

Sign up Log In